Urine biomarkers of schistosomiais and its associated bladder cancer

References

• Hu Y, Li R, Bergquist R, et al. Spatio-temporal transmission and environmental determinants of Schistosomiasis Japonica in Anhui Province, China. PLoS Negl Trop Dis 2015;9(2):e0003470
   PubMedGoogle Scholar
• Makaula P, Sadalaki JR, Muula AS, et al. Schistosomiasis in Malawi: a systematic review. Parasit Vectors 2014;7(1):570
   PubMed Web of Science ®Google Scholar
• Santos J, Gouveia MJ, Vale N, et al. Urinary estrogen metabolites and self-reported infertility in women infected with Schistosomahaematobium. PLoS One 2014;9(5):e96774
   PubMed Web of Science ®Google Scholar
• Young ND, Jex AR, Li B, et al. Whole genome sequence of Schistosomahematobium. Nat Genet 2012;44(2):221-5
   PubMed Web of Science ®Google Scholar
• Madbouly KM, Senagore AJ, Mukerjee A, et al. Colorectal cancer in a population with endemic Schistosoma mansoni: is this an at-risk population? Int J Colorectal Dis 2007;22:175-81
   PubMed Web of Science ®Google Scholar
• Charlewood GP, Shippel S, Renton H. Schistosomiasis in gynaecology. J ObstetGynaecol Br EMP 1949;56:367-85
   PubMedGoogle Scholar
• World Health Organization. Evaluation of carcinogenic risk to humans. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr 1994;61:45-119
   Google Scholar
• World Health Organization. Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report on neglected diseases. WHO/HTM/NTD/2013.1, Geneva, Switzerland; 2013
   Google Scholar
• King CH. Health metrics for helminth infections. Acta Trop 2013;10.1016/j.actatropica.2013.12.00124513037
   Web of Science ®Google Scholar
• Linsuke S, Nundu S, Mupoyi S, et al. High prevalence of Schistosoma mansoni in six health areas of - Kasansa health zone, Democratic Republic of the Congo: short report. PLoS Negl Trop Dis 2014;8(12):e3387
   PubMedGoogle Scholar
• Khaled H. Schistosomiasis and cancer in Egypt: review. J Adv Res 2013;4(5):461-6
   PubMedGoogle Scholar
• Stothard JR, Sousa-Figueiredo JC, Betson M, et al. Schistosomiasis in African infants and preschool children: let them now be treated!. Trends Parasitol 2013;29(4):197-205
   PubMed Web of Science ®Google Scholar
• World Health Organization. Accelerating work to overcome the global impact of neglected tropical diseases – a roadmap for implementation. WHO/HTM/NTD/2012.1; Geneva, Switzerland: 2012
   Google Scholar
• The World Bank. Project performance assessment report Arab Republic of Egypt national schistosomiasis control project. World Bank. 2008. Available from: http://www.wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2008/07/21/000333037_20080721033036/Rendered/PDF/444660PPAPOP0051520Box327410B01PUBLIC1.pdf [Accessed 5 March 2010]
   Google Scholar
• Cancer Statistics at the National Cancer Institute, Cairo University. Available from: http://www.nci.cu.edu.eg/lectures/Cancer_statistics2002-2007.pdf
   Google Scholar
• National Cancer Registry Program of Egypt. Available from: http://www.cancerregistry.gov.eg/reports.aspx
   Google Scholar
• Botelho MC, Sousa M. New biomarkers to fight urogenital schistosomiasis: a major neglected tropical disease. Biomark Med 2014;8(9):1061-3
   PubMed Web of Science ®Google Scholar
• Botelho MC, Alves H, Barros A, et al. The role of estrogens and estrogen receptor signaling pathways in cancer and infertility: the case of schistosomes. Trends Parasitol 2015;10.1016/j.pt.2015.03.005
   PubMed Web of Science ®Google Scholar
• Balog CI, Hensbergen PJ, Derks R, et al. Novel automated biomarker discovery work flow for urinary peptidomics. Clin Chem 2009;55(1):117-25
   PubMed Web of Science ®Google Scholar
• Idris ZM, Yazdanbakhsh M, Adegnika AA, et al. A pilot study on cytotoxic T lymphocyte-4 gene polymorphisms in urinary Schistosomiasis. Genet Test Mol Biomarkers 2012;16(6):488-92
   PubMed Web of Science ®Google Scholar
• Saad S, Eissa M, El-Bolkainy N, Eissa MS. Schistosomasis and bladder cancer, Schistosomiasis. Prof. Mohammad BagherRokni (Ed.), ISBN: 978-953-307-852-6. InTech. 2012. Available from: http://www.intechopen.com/books/schistosomiasis/schistosomasis-and-bladder-cancer
   Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69-90
   PubMed Web of Science ®Google Scholar
• Lopez-Beltran A, Cheng L. Histologic variants of Urothelial carcinoma: differential diagnosis and clinical implications. Hum Paththol 2006;37:1371-88
   PubMed Web of Science ®Google Scholar
• Felix AS, Soliman AS, Khaled H, et al. The changing patterns of bladder cancer in Egypt over the past 26 years. Cancer Causes Control 2008;19(4):421-9
   PubMed Web of Science ®Google Scholar
• Ahmad I, Barnetson RJ, Krishna NS. Keratinizing squamous metaplasia of the bladder: a review. Urol Int 2008;81(3):247-51
   PubMed Web of Science ®Google Scholar
• Heyns CF, van der Merwe A. Bladder cancer in Africa. Can J Urol 2008;15(1):3899-908
   PubMed Web of Science ®Google Scholar
• Botelho MC, et al. Tumour-like phenotypes in urothelial cells after exposure to antigens from eggs of Schistosomahae- matobium: An oestrogen–DNA adducts mediated pathway? Int J Parasitol 2013;43(1):17-26
   PubMed Web of Science ®Google Scholar
• Khaled H, El Hattab O, Abdel Moneim D, et al. A prognostic index (bladder prognostic index) for Schistosomal-related invasive bladder cancer. Urol Oncol 2005;23:245-60
   Web of Science ®Google Scholar
• Sherif M, Ibrahim AS. The incidence of cancer in Egypt. In: The Profile of Cancer in Egypt (CRMCA). Arab World Printing House; Cairo: 1987. p. 179
   Google Scholar
• Ghoneim MA, EL Mekresh MM, EL Baz MA, et al. “Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1026 cases”. J Urol 1997;158:393-9
   PubMed Web of Science ®Google Scholar
• Khaled HM, Gad EL Mawla N, EL Said A, et al. Combination chemotherapy for advanced ilharzial bladder carcinoma. Ann Oncol 1996;7:751-4
   PubMed Web of Science ®Google Scholar
• Fadl-Elmula I, Kytola S, Leithy ME, et al. Chromosomal aberrations in benign and malignant bilharzia-associated bladder lesions analyzed by comparative genomic hybridization. BMC Cancer 2002;2:5
   PubMed Web of Science ®Google Scholar
• Gonzalez-Zulueta M, Shibata A, Ohneseit PF, et al. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder. J Natl Cancer Inst 1995;87(18):1383-93
   PubMed Web of Science ®Google Scholar
• Muscheck M, Abol-Enein H, Chew K, et al. Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization. Carcinogenesis 2000;21(9):1721-6
   PubMed Web of Science ®Google Scholar
• Fadl-Elmula I, Gorunova L, Lundgren R, et al. Chromosomal abnormalities in two bladder carcinomas with secondary squamous cell differentiation. Cancer Genet Cytogenet 1998;102(2):125-30
   PubMed Web of Science ®Google Scholar
• Habuchi T, Takahashi R, Yamada H, et al. Influence of cigarette smoking and Schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Res 1993;53(16):3795-9
   PubMed Web of Science ®Google Scholar
• Ramchurren N, Cooper K, Summerhayes IC. Molecular events underlying schistosomiasis-related bladder cancer. Int J Cancer 1995;62(3):237-44
   PubMed Web of Science ®Google Scholar
• Warren W, Biggs PJ, el-Baz M, et al. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours. Carcinogenesis 1995;16(5):1181-9
   PubMed Web of Science ®Google Scholar
• Przybojewska B, Jagiello A, Jalmuzna P. H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers. Cancer Genet Cytogenet 2000;121(1):73-7
   PubMed Web of Science ®Google Scholar
• Guo CC, Gomez E, Tamboli P, et al. Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases. Hum Pathol 2009;40(10):1448-52
   PubMed Web of Science ®Google Scholar
• Botelho M, Ferreira AC, Oliveira MJ, et al. Schistosoma haematobium total antigen induces increased proliferation, migration and invasion, and decreases apoptosis of normal epithelial cells. Int J Parasitol 2009;39(10):1083-91
   PubMed Web of Science ®Google Scholar
• Badawi AF, Cooper DP, Mostafa MH, et al. O6-alkylguanine-DNA alkyltransferase activity in schistosomiasis-associated human bladder cancer. Eur J Cancer 1994;30A(9):1314-19
   PubMed Web of Science ®Google Scholar
• Yossepowitch O, Herr HW, Donat SM. Use of urinary biomarkers for bladder cancer surveillance: patient perspectives. J Urol 2007;177(4):1277-82; discussion 1282
   PubMed Web of Science ®Google Scholar
• Yutkin V, Nisman B, Pode D. Can urinary biomarkers replace cystoscopic examinationin bladder cancer surveillance? Expert Rev Anticancer Ther 2010;10(6):787-90
   PubMed Web of Science ®Google Scholar
• Shariat SF, Ashfaq R, Sagalowsky AI, et al. Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma. J Urol 2007;177:481-7
   PubMed Web of Science ®Google Scholar
• Shariat SF, Karakiewicz PI, Ashfaq R, et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer 2008;112:315-25
   PubMed Web of Science ®Google Scholar
• Badr S, Salem A, Yuosif AH, et al. Hypoxia inducible factor-1alpha and microvessel density as angiogenic factors in Schistosomal and non-Schistosomal bladder cancer. Clin Lab 2013;59(7-8):805-12
   PubMed Web of Science ®Google Scholar
• Eissa S, Zohny SF, Zekri AR, et al. Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence. Med Oncol 2010;27:1286-94
   PubMed Web of Science ®Google Scholar
• Eissa S, Matboli M, Mansour A, et al. Evaluation of urinary HURP mRNA as a marker for detection of bladder cancer: relation to Schistosomiasis. Med Oncol 2014;31(2):804
   PubMed Web of Science ®Google Scholar
• Abd El Gawad IA, Moussa HS, Nasr MI, et al. Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer. J Egypt Natl Canc Inst 2005;17(3):193-202
   PubMedGoogle Scholar
• Eissa S, Labib RA, Mourad MS, et al. Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer. Eur Urol 2003;44(6):687-94
   PubMed Web of Science ®Google Scholar
• Eissa S, Swellam M, el-Mosallamy H, et al. Diagnostic value of urinary molecular markers in bladder cancer. Anticancer Res 2003;23(5b):4347-55
   PubMed Web of Science ®Google Scholar
• El-Gendy SM, Abdel Salam IM, Abd El-Wahab N, et al. Urinary telomerase activity, c-erbB2, malondialdehyde and nitric oxide as possible biological markers of bladder cancer. Turk J Biochem 31(4):164-8
   Google Scholar
• Elmansy H, Kotb A, Hammam O, et al. Prognostic impact of apoptosis marker Fas (CD95) and its ligand (FasL) on bladder cancer in Egypt: study of the effect of schistosomiasis. Ecancermedicalscience 2012;6:278
   PubMedGoogle Scholar
• Eissa S, Swellam M, Shehata H, et al. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer. J Urol 2010;183(2):493-8
   PubMed Web of Science ®Google Scholar
• Eissa S, Badr S, Barakat M, et al. The diagnostic efficacy of urinary survivin and hyaluronidase mRNA as urine markers in patients with bladder cancerClin Lab 2013;59(7-8):893-900
   PubMed Web of Science ®Google Scholar
• Helmy A, Hammam OA, El Lithy TR, El DeenWishahi MM. The role of TGF-beta-1 protein and TGF-beta-R-1 receptor in immune escape mechanism in bladder cancer. MedGenMed 2007;9(4):34
   PubMedGoogle Scholar
• Toyota M, Yamamoto E. DNA methylation changes in cancer. Prog Mol Biol Transl Sci 2011;101:447-57
   PubMed Web of Science ®Google Scholar
• Zhong X, Isharwal S, Naples JM, et al. Hypermethylation of genes detected in urine from Ghanaian adults with bladder pathology associated with Schistosoma haematobium infection. PLoS One 2013;8(3):e59089
   PubMedGoogle Scholar
• Eissa S, Swellam M, El-Khouly IM, et al. Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of Schistosomal and nonSchistosomal bladder cancer. Cancer Epidemiol Biomarkers Prev 2011;20(8):1657-64
   PubMed Web of Science ®Google Scholar
• Miah S, Dudziec E, Drayton RM, et al. An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer. Br J Cancer 2012;107(1):123-8
   PubMed Web of Science ®Google Scholar
• Han Y, Liu Y, Nie L, et al. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder. Urology 2013;81:209.e1-7
   PubMed Web of Science ®Google Scholar
• Noon AP, Catto JW. Noncoding RNA in bladder cancer: a specific focus upon high-risk nonmuscle invasive disease. CurrOpin Urol 2014;24(5):506-11
   Web of Science ®Google Scholar
• Eissa S, Matboli M, Hegazy MG, et al. Evaluation of urinary microRNA panel in bladder cancer diagnosis: relation to Schistosomiasis. Transl Res 2015; pii: S1931-5244(15)00003-1
   Web of Science ®Google Scholar
• Eissa S, Habib H, Ali E, Kotb Y. Evaluation of urinary miRNA-96 as a potential biomarker for bladder cancer diagnosis. Med Oncol 2015;32(1):413
   PubMed Web of Science ®Google Scholar
• Eissa S, Swellam M, Labib RA, et al. A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot. J Urol 2009;181(3):1353-60
   PubMed Web of Science ®Google Scholar
• Moses MA, Wiederschain D, Loughlin KR, et al. Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res 1998;58:1395-9
   PubMed Web of Science ®Google Scholar
• Yan L, Borregaard N, Kjeldsen L, Moses MA. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 2001;276:37258-65
   PubMed Web of Science ®Google Scholar
• Gerhards S, Jung K, Koenig F, et al. Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma. Urology 2001;57:675-9
   PubMed Web of Science ®Google Scholar
• Eissa S, Ali-Labib R, Swellam M, et al. Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine. Eur Urol 2007;52(5):1388-96
   PubMed Web of Science ®Google Scholar
• Mohammed MA, Seleim MF, Abdalla MS, et al. Urinary high molecular weight matrix metalloproteinases as non-invasive biomarker for detection of bladder cancer. BMC Urol 2013;13:25
   PubMedGoogle Scholar
• Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997;242:27-33
   PubMed Web of Science ®Google Scholar
• Eissa S, Shehata H, Mansour A, et al. Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer. Med Oncol 2012;29:3345-51
   PubMed Web of Science ®Google Scholar
• Nossier AI, Eissa S, Ismail MF, et al. Direct detection of hyaluronidase in urine using cationic gold nanoparticles: a potential diagnostic test for bladder cancer. Biosens Bioelectron 2014;54:7-14
   PubMed Web of Science ®Google Scholar
• Eissa S, Swellam M, Sadek M, et al. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors. J Urol 2002;168(2):465-9
   PubMed Web of Science ®Google Scholar
• El Mrini M. Xylinas. E, Diagnostic and prognostic markers in non-muscle invasive bladder cancer. Rev Prat 2014;64(10):1386-7; French. No abstract available
   PubMedGoogle Scholar
• Azzazy HM, Mansour MM, Kazmierczak SC. Nanodiagnostics: a new frontier for clinical laboratory medicine. Clin Chem 2006;52(7):1238-46
   PubMed Web of Science ®Google Scholar
• Christof MN. Nanoparticles, proteins, and nucleic acids: biotechnology meets materials science. Angew Chem Int Ed 2001;40(22):4128-58
   PubMed Web of Science ®Google Scholar
• Zheng J, Nicovich PR, Dickson RM. Highly fluorescent noble-metal quantum dots. Annu Rev Phys Chem 2007;58:409-31
   PubMed Web of Science ®Google Scholar
• Zheng J, Petty JT, Dickson RM. High quantum yield blue emission from water-soluble Au8 nanodots. J Am Chem Soc 2003;125(26):7780-1
   PubMed Web of Science ®Google Scholar
• Eissa S, Shawky SM, Matboli M, et al. Direct detection of unamplified hepatoma upregulated protein RNA in urine using gold nanoparticles for bladder cancer diagnosis. Clin Biochem 2014;47(1-2):104-10
   PubMed Web of Science ®Google Scholar